Fresh hope of protection against the H1N1 flu outbreak emerged on Friday when the government said it had signed a £450m agreement to reserve scarce manufacturing capacity for 90m doses of vaccine by the end of the year.

The contract, which individuals close to the talks estimated to be worth about £5 a dose, may spark international concerns as some richer countries negotiate with producers for privileged access to limited supplies of a pandemic vaccine.